NCT00680836View on ClinicalTrials.gov

Gulf War Digestive Health Study

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2013

Conditions
Irritable Bowel SyndromeSmall Intestinal Bacterial Overgrowth
Interventions
DRUG

Placebo

orally two times per day for 14 days

DRUG

Rifaximin

550 mg orally two times per day for 14 days

Trial Locations (1)

84132

Division of Epidemiology, Salt Lake City

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00680836 - Gulf War Digestive Health Study | Biotech Hunter | Biotech Hunter